News & Perspective
Drugs & Diseases
CME & Education
Video
Decision Point

Specialty: Multispecialty
Allergy & Immunology
Anesthesiology
Cardiology
Critical Care
Dermatology
Diabetes & Endocrinology
Emergency Medicine
Family Medicine
Gastroenterology
General Surgery
Hematology - Oncology
HIV/AIDS
Hospital Medicine
Infectious Diseases
Internal Medicine
Multispecialty
Nephrology
Neurology
Ob/Gyn & Women's Health
Oncology
Ophthalmology
Orthopedics
Pathology & Lab Medicine
Pediatrics
Plastic Surgery
Psychiatry
Public Health
Pulmonary Medicine
Radiology
Rheumatology
Transplantation
Urology
Today on Medscape
Business of Medicine
Medical Lifestyle
Science & Technology
Medical Students
Nurses
Pharmacists
Residents
Edition: English

Medscape

English
Deutsch
Español
Français
Português
UKNew

Univadis

Sign Up It's Free!
English Edition

Medscape

Univadis

    X
    Univadis from Medscape

    No Results

      Friday, January 10, 2025
      News & Perspective Drugs & Diseases CME & Education Video Decision Point

      From Medscape Rheumatology

      Coverage from the

      American College of Rheumatology (ACR) 2024 Annual Meeting

      November 14 - 19, 2024; Washington, D.C.

      November 14 - 19, 2024 Washington, D.C.

      Conference News

      Medscape Rheumatology© 

      Popular News From ACR 2023

      • Novel Blood Test Can Detect Rheumatoid Arthritis Novel Blood Test Can Detect Rheumatoid Arthritis An experimental assay detects epigenetic features within the unique patterns and sizes of cell-free DNA found in blood, but is it better than clinical diagnostics?
        Medscape Medical News, Nov 20, 2023
      • Split-Dose Methotrexate Speeds RA Response Over Single Dose Split-Dose Methotrexate Speeds RA Response Over Single Dose Compared with a single dose, more patients in the split-dose group had improved disease activity at 16 weeks, and fewer needed additional DMARDs, but the effect was not found at 24 weeks.
        Medscape Medical News, Nov 16, 2023
      • Pregnancy in Rheumatic Disease Quadruples CVE Risk Pregnancy in Rheumatic Disease Quadruples CVE Risk Pregnant patients with lupus and concomitant APS had an 18-fold higher risk for a cardiovascular event during and up to 6 weeks postpartum than did pregnant individuals without these conditions.
        Medscape Medical News, Nov 12, 2023

      Previous Coverage

      Find Us On
      About
      About Medscape Privacy Policy Editorial Policy Cookies Manage Preferences Terms of Use Advertising Policy Help Center
      Membership
      Become a Member About You Professional Information Newsletters & Alerts Market Research
      App
      Medscape
      Editions
      English Deutsch Español Français Português
      All material on this website is protected by copyright, Copyright © 1994-2025 by WebMD LLC. This website also contains material copyrighted by 3rd parties.